FDA approves Amgen's treatment for most deadly form of lung cancer
The agency cleared the drug, called Imdelltra, as a second or later-line treatment for adults with advanced small-cell lung cancer.
Source: nbclosangeles.com
Stay updated with breaking news from Amgen Bradner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The agency cleared the drug, called Imdelltra, as a second or later-line treatment for adults with advanced small-cell lung cancer.
The FDA cleared the Amgen drug, called Imdelltra, as a treatment for patients with advanced small-cell lung cancer.